| Dr Marc Aaron Stiefel, MD | |
|
599 W State St, Suite 201, Doylestown, PA 18901-2567 | |
| (215) 345-5323 | |
| (215) 345-5329 |
| Full Name | Dr Marc Aaron Stiefel |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 23 Years |
| Location | 599 W State St, Doylestown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578583647 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD428221 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doylestown Hospital | Doylestown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Ent Alliance Llc | 7416963988 | 39 |
News Archive
Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.
Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.
People affected by paralysis could enjoy more independence, better health and a higher quality of life thanks to an innovative system designed to improve fitness and increase arm strength.
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
› Verified 1 days ago
| Entity Name | Pinnacle Ent Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538230313 PECOS PAC ID: 7416963988 Enrollment ID: O20060222000064 |
News Archive
Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.
Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.
People affected by paralysis could enjoy more independence, better health and a higher quality of life thanks to an innovative system designed to improve fitness and increase arm strength.
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marc Aaron Stiefel, MD 599 W State St, Suite 201, Doylestown, PA 18901-2567 Ph: (215) 345-5323 | Dr Marc Aaron Stiefel, MD 599 W State St, Suite 201, Doylestown, PA 18901-2567 Ph: (215) 345-5323 |
News Archive
Allergan, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter to its New Drug Application for LEVADEX (dihydroergotamine) inhalation aerosol for the acute treatment of migraine in adults.
Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.
People affected by paralysis could enjoy more independence, better health and a higher quality of life thanks to an innovative system designed to improve fitness and increase arm strength.
One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.
› Verified 1 days ago
Dr. Brent R Rosen, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3655 Route 202, Suite 225-230, Doylestown, PA 18902 Phone: 215-230-4013 Fax: 215-230-4143 | |
Dr. Douglas Mark Nadel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 599 W State St Ste 201, The Pavilion At Doylestown Hospital, Doylestown, PA 18901 Phone: 215-345-5323 Fax: 215-345-5329 |